Immunic, Inc. (IMUX)
NASDAQ: IMUX · Real-Time Price · USD
15.16
+0.13 (0.86%)
Jul 17, 2026, 4:00 PM EDT - Market closed
Immunic Market Cap
Immunic has a market cap or net worth of $206.5 million as of July 17, 2026. Its market cap has increased by 140.59% in one year.
Market Cap
206.50M
Enterprise Value
20.29M
1-Year Change
140.59%
Ranking
Category
Stock Price
$15.16
ChartMarket Cap Chart
Since April 15, 2019, Immunic's market cap has decreased from $243.61M to $206.50M, a decrease of -15.23%. That is a compound annual growth rate of -2.25%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 17, 2026 | 206.50M | 221.67% |
| Dec 31, 2025 | 64.20M | -28.73% |
| Dec 31, 2024 | 90.08M | 33.02% |
| Dec 29, 2023 | 67.72M | 9.04% |
| Dec 30, 2022 | 62.10M | -75.28% |
| Dec 31, 2021 | 251.21M | -20.70% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Apr 15, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Coherus Oncology | 214.41M |
| Whitehawk Therapeutics | 213.52M |
| Keros Therapeutics | 212.76M |
| Precision BioSciences | 211.84M |
| NovaBridge Biosciences | 208.17M |
| Atrium Therapeutics | 207.41M |
| Nautilus Biotechnology | 207.14M |
| Agenus | 204.88M |